| Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr (NCT06799624) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2026-01-01 |
| Microbiota-guided Radiotherapy for Head and Neck Cancer (NCT07253402) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2025-10-15 |
| Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer (NCT06938724) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2025-07-25 |
| Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma (NCT06986486) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2025-06-01 |
| Revisiting the Concept of Nerve Sparing Radical Hysterectomy (NCT06999824) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2025-06-01 |
| Immunological Phenotype of Desmoid-fibromatosis-affected Patients. (NCT07496242) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2025-05-27 |
| Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments (NCT06862934) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2025-03-20 |
| A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma (NCT07507578) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2025-03-01 |
| Matching Primary Tumor and Blood Gene Expression Analysis of HPV-negative Squamous Head and Neck Cancers (NCT07512921) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2025-02-18 |
| Xpert Bladder Monitor: a Non-Invasive Follow-Up Tool for Detecting Relapse in High Grade or High Risk Bladder Cancer (NCT06751667) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2025-01-01 |
| Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer (NCT06528483) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-12-02 |
| Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients (NCT06800391) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-11-22 |
| A Composite Assay for HER2-positive Early-stage Breast Cancer Management (NCT06762977) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-11-13 |
| High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma (NCT06480396) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-11-01 |
| A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL) (NCT06594679) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-09-26 |
| Validation of the European Oncology Quality of Life Toolkit (NCT05947903) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-08-31 |
| Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare) (NCT07461246) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-05-13 |
| Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project (NCT06351228) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-03-30 |
| Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS) (NCT06361784) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-03-29 |
| Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer (NCT06726291) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-02-26 |
| RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study (NCT07030569) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2024-02-01 |
| Effects of Diet and Osteopathy on Quality of Life and Inflammation in Breast Cancer Patients Under Hormonal Therapy (NCT06164119) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-12-19 |
| The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN) (NCT06408441) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-12-01 |
| Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC) (NCT06086288) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-11-01 |
| A Retrospective Study on Multiple Classifier Endometrial Cancer (NCT05976113) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-07-27 |
| Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial (NCT05763992) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-05-15 |
| Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study (NCT06805812) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-05-01 |
| AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs (NCT06320184) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-04-30 |
| Pilot Study on the Use of iENTER, iCONSENT and iPARTICIPATE E-tools (NCT06317961) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-04-05 |
| Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment (NCT05649943) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-03-01 |
| Multiomics Approach in Metastatic Clear Renal Cell Carcnoma (NCT05782400) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-02-28 |
| Indocyanine Green-guided Lymphadenectomy in Laparoscopic Total Mesorectal Excision for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy (NCT05873621) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-01-01 |
| FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction (NCT05703997) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-01-01 |
| The ImmunoXXL Study (NCT05879328) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-12-23 |
| I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy (NCT05537922) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-10-01 |
| APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch (NCT05550961) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-10-01 |
| Gene Expression Profile of Resected Pancreatic and Ampullary Adenocarcinoma at Favorable Prognosis (NCT05754788) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-09-19 |
| The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers (NCT05483374) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-05-31 |
| Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy (NCT05031975) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-05-02 |
| Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy (NCT05951699) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-04-28 |
| Big Data for Quality of Life in Head and Neck Cancer (NCT05315570) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-03-28 |
| Quantifying Systemic Immunosuppression to Personalize Cancer Therapy (NCT05621837) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-03-10 |
| Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History. (NCT05284305) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-03-01 |
| Predictors of Node Positivity in Endometrial Cancer (NCT05793333) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-01-10 |
| TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients (NCT05316922) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-12-13 |
| Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer (NCT05136326) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-12-01 |
| Palliative Care Referral System (PCRS) for Cancer Patients With Advanced Disease (NCT04936568) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-07-14 |
| Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE) (NCT05372302) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-07-08 |
| Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC) (NCT06057298) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-06-15 |
| Non-invasive Detection of Breast Cancer by Breath Analysis (NCT06499077) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-06-03 |
| Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC) (NCT06091683) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-04-30 |
| Epithelioid Haemangioendothelioma Observational Study (NCT06680401) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-02-25 |
| Radiomics and Molecular Classification in Endometrial Cancer (NCT06963385) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-01-15 |
| 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer. (NCT04689347) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-01-01 |
| The TI.VA Algorithm: A First-in-Humans Test. (NCT05199883) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-12-01 |
| A Comparison Between TOF Watch® SX and Tetragraph® (NCT04947306) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-08-24 |
| Radiomics and Machine Learning in the Diagnosis of Ovarian Masses (NCT06342934) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-07-22 |
| Multimodality Treatments of HPV-related Lesions of the Female Genital Tract (NCT05938192) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-07-15 |
| Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment (NCT04435964) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-06-25 |
| A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET (NCT04427787) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-06-20 |
| Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer (NCT04943406) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-05-08 |
| Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer (NCT04248998) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-05-05 |
| Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients (NCT05615883) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-01-20 |
| The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. (NCT04403867) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-01-02 |
| Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia (NCT06611020) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-01-01 |
| Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases (NCT04001725) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-10-15 |
| hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study" (NCT03824691) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-09-25 |
| Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen) (NCT03943602) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-08-01 |
| Screening and Multiple Intervention on Lung Epidemics (NCT03654105) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-07-23 |
| FOUND - Ancillary Study to Smile Protocol NCT03654105 (NCT04441814) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-07-23 |
| Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue Sarcomas (NCT04225494) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-06-01 |
| PATIENT VOICES Integration of Systematic Assessment of Patient Reported Outcomes Within Clinical Oncology Practice (NCT03968718) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-05-27 |
| Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study (NCT03832673) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-05-22 |
| NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer (NCT03832621) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-03-25 |
| Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma (NCT03464734) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-01-16 |
| Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation (NCT03803436) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-01-02 |
| Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients (NCT05321329) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-12-03 |
| Prospective Translational Study Investigating Predictors of Outcome in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab (I-Rene Trial) (NCT04891055) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-11-29 |
| Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance (NCT03666325) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-10-01 |
| Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer. (NCT03467178) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-07-30 |
| Cancer Anesthesia and Frailty (NCT03575416) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-07-03 |
| Impact of Dietary Intervention on Tumor Immunity: the DigesT Trial (NCT03454282) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-07-01 |
| A Study of CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinoma (NCT03463681) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-06-11 |
| Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer (NCT03539328) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-06-01 |
| Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors. (NCT03447678) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-05-23 |
| NICSO National Study: Physician - Nurse Monitoring Project About Oncological Adverse Events (NCT04726020) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-03-01 |
| Duodenal Polyposis Classification in FAP (NCT07199127) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-02-02 |
| caBozantinib in cOllectiNg ductS Renal Cell cArcInoma (NCT03354884) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-01-12 |
| Preventive Anti-inflammatory Diet to Reduce Gastro-intestinal Inflammation in FAP Patients: a Prospective Pilot Study (NCT04552405) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-09-12 |
| Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer (NCT04302714) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-03-20 |
| A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease. (NCT03103724) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-03-16 |
| Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) (NCT03449173) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-03-02 |
| Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma (NCT02736266) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-02-27 |
| Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer (NCT03294122) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-02-02 |
| Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors (NCT03081923) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-02-01 |
| Nutritional Status in Retroperitoneal Sarcoma. (NCT03877588) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2016-12-06 |
| Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers (NCT02934464) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2016-12-01 |
| REtroperitoneal SArcoma Registry: an International Prospective Initiative (NCT03838718) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2016-09-01 |
| Second Line Sorafenib After Pazopanib in Patients With RCC (NCT02122003) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2016-09-01 |
| DianaWeb: Before and After Study Online Based Participatory Research on Breast Cancer Women (NCT05057598) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2016-06-21 |